Remed Co.,Ltd. (KOSDAQ:302550)
South Korea · Delayed Price · Currency is KRW 2,625.00
+120.00 (4.79%)
At close: Nov 13, 2026
Remed Market Cap
Remed has a market cap or net worth of 77.43 billion as of November 13, 2026. It is the 29,137th most valuable company in the world and the 1,432nd biggest in South Korea. Its market cap has decreased by 23.17% in one year.
Market Cap
77.43B
Enterprise Value
74.45B
Revenue
27.05B
Global Rank
Country Rank
#1,432 South Korea
PE Ratio
55.23
ChartMarket Cap Chart
Since August 14, 2018, Remed's market cap has increased from 73.83B to 77.43B, an increase of 4.87%. That is a compound annual growth rate of 0.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 77.43B | -18.39% |
| Dec 30, 2025 | 94.88B | -13.97% |
| Dec 30, 2024 | 110.30B | 10.60% |
| Dec 28, 2023 | 99.73B | 31.78% |
| Dec 29, 2022 | 75.68B | -53.48% |
| Dec 30, 2021 | 162.69B | -18.29% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 14, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Mezoo | 153.17B |
| MEDIANA Co.,Ltd | 140.41B |
| L&K Biomed | 111.31B |
| Hironic | 66.99B |
| SELVAS Healthcare | 61.72B |
| DRGEM | 53.17B |
| Dynamic solution | 50.29B |
| Genoray | 39.98B |